Characteristic

N

N of events

Cumulative OS at 12 ms (%)

Cumulative OS at 36 ms (%)

Cumulative OS at 60 ms (%)

Median OS estimate (ms)

P-value

Whole cohort:

42

22

69.4

35.7

26.8

20.23

NA

Gender:

Male

Female

27

15

13

9

74.1

61.5

39.1

30.8

NR

30.8

26.84

12.86

0.454

Age categories:

≤50

>50

≤60

>60

10

32

24

18

3

19

13

9

100

60.2

69.5

88.1

51.4

28.2

31.3

44.1

51.4

NR

20.9

NR

NR

13.29

20.23

26.84

0.085

0.657

Residence:

Rural

Urban

29

13

14

8

67.7

72.7

33.2

36.4

33.2

NR

20.23

15.36

0.662

Main complaint:

Hematuria

Others

37

5

18

4

74.8

26.7

40.4

NR

30.3

NR

26.84

5.16

0.007

Tumor growth:

Fungating

Ulcerative

35

7

21

1

70.9

80

29.1

80

19.4

NR

16.48

NR

0.108

Tumor Size (cm)

≤5

>5

24

18

14

8

67.3

72.4

36.2

24.8

24.2

NR

16.48

20.23

0.694

Tumor location:

Posterior wall

Other sites

25

17

12

10

70.4

66.7

51.2

16.7

34.1

NR

44.80

13.58

0.296

Tumor grade:

II

III

33

9

16

6

67.7

75.0

41.0

NR

30.7

NR

26.84

12.86

0.279

Hydronephrosis:

Present

Absent

22

20

15

7

58.8

81.9

17.8

60.6

NR

30.3

13.29

44.80

0.065

Pathology:

AC (NOS)

MAC & SRAC

32

10

16

6

70.4

66.7

38.0

33.3

NR

33.3

20.29

13.28

0.600

Bilharziasis:

Present

Absent

15

27

8

14

59.1

74.7

26.3

43.2

26.3

NR

12.73

20.23

0.623

Clinical stage^#

Stage II

Stage III & IV

28

14

10

12

82.5

46.2

52.0

7.7

39.0

NR

44.80

7.93

<0.001

Curative Sx (n = 27):

RC + PC

APE

22

5

9

2

82.4

80

44.6

60

NR

60

32.24

NR

0.735

pT (n = 27):

pT2

pT3 & 4

9

18

2

9

100

73.3

75

38.1

NR

NR

44.8

20.3

0.116

pN (n = 27):

Negative

Positive

22

5

8

3

88.9

50.0

55.9

NR

41.9

NR

44.80

6.84

0.037